In the American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE) comprehensive T2DM 2017 management algorithm, insulin is recommended for T2DM patients presenting with symptoms of hyperglycaemia and an HbA1c > 9.0% [6]. This evidence concerns the gene INS and Hyperglycemia.